SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-10-013040
Filing Date
2010-03-22
Accepted
2010-03-22 12:25:44
Documents
2
Period of Report
2010-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2316
2 POWER OF ATTORNEY poa1.htm EX-24.1 8860
  Complete submission text file 0001140361-10-013040.txt   13184
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MANHATTAN PHARMACEUTICALS, INC. 48 WALL STREET NEW YORK NY 10005
Business Address
Shimko David (Reporting) CIK: 0001486821 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32639 | Film No.: 10696004